Erkki Ruoslahti
#19,497
Most Influential Person Now
American medical researcher
Erkki Ruoslahti's AcademicInfluence.com Rankings
Erkki Ruoslahtilaw Degrees
Law
#347
World Rank
#494
Historical Rank
#216
USA Rank
Common Law
#2
World Rank
#2
Historical Rank
#2
USA Rank
Erkki Ruoslahtibiology Degrees
Biology
#530
World Rank
#929
Historical Rank
#305
USA Rank
Cell Biology
#11
World Rank
#11
Historical Rank
#7
USA Rank
Download Badge
Law Biology
Erkki Ruoslahti's Degrees
- Masters Medicine University of Helsinki
- PhD Cell Biology University of Helsinki
Why Is Erkki Ruoslahti Influential?
(Suggest an Edit or Addition)According to Wikipedia, Erkki Ruoslahti is a cancer researcher and distinguished professor at Sanford Burnham Prebys Medical Discovery Institute. He moved from Finland to the United States in 1976. Ruoslahti made seminal contributions to biology of extracellular matrix and its receptors. He was one of the discoverers of fibronectin, an adhesion molecule and component of extracellular matrices, and he subsequently identified and cloned a number of other extracellular matrix components and adhesion molecules. In 1984, he identified the sequence within fibronectin that mediates cell attachment, called RGD for the amino acids of which it’s composed, and isolated the cellular receptors that bind that sequence, now known as integrins. The RGD discovery has led to the development of drugs for vascular thrombosis and cancer, among other diseases.
Erkki Ruoslahti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- New perspectives in cell adhesion: RGD and integrins. (1987) (4624)
- Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule (1984) (3366)
- RGD and other recognition sequences for integrins. (1996) (2967)
- Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. (1998) (2019)
- Binding of soluble form of fibroblast surface protein, fibronectin, to collagen (1977) (1852)
- Biodegradable luminescent porous silicon nanoparticles for in vivo applications. (2009) (1656)
- Negative regulation of transforming growth factor-β by the proteoglycan decorin (1990) (1415)
- Nanocrystal targeting in vivo (2002) (1366)
- Proteoglycans as modulators of growth factor activities (1991) (1321)
- Fibronectin and its receptors. (1988) (1311)
- Arg-Gly-Asp: A versatile cell recognition signal (1986) (1274)
- Integrins and anoikis. (1997) (1204)
- Organ targeting In vivo using phage display peptide libraries (1996) (1195)
- Transforming growth factor-beta in disease: the dark side of tissue repair. (1992) (1172)
- Control of adhesion-dependent cell survival by focal adhesion kinase (1996) (1160)
- Anchorage dependence, integrins, and apoptosis (1994) (1085)
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 (1990) (1028)
- Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor (1985) (1027)
- Integrin signaling. (1999) (1025)
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease (1992) (1018)
- Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. (1994) (1000)
- Tissue-penetrating delivery of compounds and nanoparticles into tumors. (2009) (953)
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs (2010) (933)
- Anti-cancer activity of targeted pro-apoptotic peptides (1999) (872)
- Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. (2000) (855)
- Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. (1986) (851)
- Targeting of drugs and nanoparticles to tumors (2010) (820)
- Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. (1993) (816)
- αv Integrins as receptors for tumor targeting by circulating ligands (1997) (756)
- Laminin promotes neuritic regeneration from cultured peripheral and central neurons (1983) (724)
- Specialization of tumour vasculature (2002) (678)
- Fibronectin: current concepts of its structure and functions. (1980) (675)
- Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. (1984) (667)
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration (2009) (658)
- The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. (1995) (656)
- Structure and biology of proteoglycans. (1988) (644)
- Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. (1987) (614)
- Multiple domains of the large fibroblast proteoglycan, versican. (1989) (598)
- Tumor targeting with a selective gelatinase inhibitor (1999) (578)
- Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. (1990) (563)
- The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. (1985) (552)
- Amino acid sequence of the human fibronectin receptor (1987) (550)
- Fibronectin: purification, immunochemical properties, and biological activities. (1982) (521)
- Proteoglycans in cell regulation. (1989) (516)
- Affinity of fibronectin to collagens of different genetic types and to fibrinogen (1978) (502)
- Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium (2013) (500)
- Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging (2008) (498)
- Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas (1981) (495)
- αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF (1997) (485)
- A tumor-homing peptide with a targeting specificity related to lymphatic vessels (2002) (473)
- Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins (1995) (468)
- Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. (1998) (468)
- Nanoparticles that communicate in vivo to amplify tumour targeting. (2011) (462)
- Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. (1986) (452)
- Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels (2003) (450)
- Brain extracellular matrix. (1996) (446)
- A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. (1985) (442)
- Negative regulation of transforming growth factor-beta by the proteoglycan decorin. (1990) (433)
- Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases (1996) (430)
- Regulation of the fibronectin receptor affinity by divalent cations. (1988) (428)
- Biomimetic amplification of nanoparticle homing to tumors (2007) (419)
- Integrin Activation by R-ras (1996) (418)
- Serum spreading factor (vitronectin) is present at the cell surface and in tissues. (1983) (412)
- Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule (1981) (399)
- Association of insulin receptor substrate-1 with integrins. (1994) (388)
- Role of the alpha v beta 3 integrin in human melanoma cell invasion. (1992) (387)
- Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage (1996) (379)
- Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. (1990) (379)
- Targeted quantum dot conjugates for siRNA delivery. (2007) (377)
- Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. (2004) (376)
- Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. (1990) (376)
- Fibronectin and its integrin receptors in cancer. (1999) (366)
- Activation of protein kinase C precedes alpha 5 beta 1 integrin-mediated cell spreading on fibronectin. (1993) (359)
- Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles (2012) (355)
- Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. (1985) (352)
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. (1994) (335)
- Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. (1990) (332)
- Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. (1998) (332)
- Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site (1986) (323)
- Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. (1985) (323)
- Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. (1993) (323)
- Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor (1989) (318)
- Hyaluronate binding properties of versican. (1992) (312)
- Integrins and tumor cell dissemination. (1989) (307)
- Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. (2008) (307)
- Superfibronectin is a functionally distinct form of fibronectin (1994) (303)
- Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library (1994) (303)
- Tyrosine Phosphorylation of p130Cas and Cortactin Accompanies Integrin-mediated Cell Adhesion to Extracellular Matrix (*) (1995) (300)
- Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides [published erratum appears in J Cell Biol 1989 Jun;108(6):following 2546] (1988) (299)
- Targeting the prostate for destruction through a vascular address (2002) (298)
- Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. (1999) (298)
- The human laminin receptor is a member of the integrin family of cell adhesion receptors. (1988) (295)
- Cooperative nanomaterial system to sensitize, target, and treat tumors (2009) (294)
- A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo (2002) (292)
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma (2011) (290)
- Tumor penetrating peptides for improved drug delivery (2017) (287)
- Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. (2008) (287)
- Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin (1975) (284)
- A cell surface receptor complex for collagen type I recognizes the Arg- Gly-Asp sequence (1987) (284)
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation (2010) (283)
- Detachment of cells from culture substrate by soluble fibronectin peptides (1985) (283)
- Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain* (2000) (282)
- Distribution of fibroblast surface antigen in the developing chick embryo (1975) (280)
- Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. (2009) (278)
- Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. (2004) (269)
- The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. (1997) (269)
- Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. (1981) (268)
- A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). (1990) (264)
- Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. (1992) (262)
- Basement membrane glycoprotein laminin binds to heparin (1980) (256)
- Studies of carcino‐fetal proteins. III. Development of a radioimmunoassay for α‐fetoprotein. Demonstration of α‐fetoprotein in serum of healthy human adults (1971) (251)
- Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. (2003) (248)
- Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. (1981) (246)
- Stretching Is Good for a Cell (1997) (246)
- Alpha 2 beta 1 integrins from different cell types show different binding specificities. (1990) (245)
- Fibronectin Matrix Regulates Activation of RHO and CDC42 GTPases and Cell Cycle Progression (1998) (245)
- alpha-Fetoprotein in cancer and fetal development. (1979) (244)
- A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin (1993) (244)
- Remotely Triggered Release from Magnetic Nanoparticles (2007) (240)
- Targeting atherosclerosis by using modular, multifunctional micelles (2009) (240)
- Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation (1988) (239)
- An address system in the vasculature of normal tissues and tumors. (2000) (239)
- Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery (2009) (237)
- Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix (1979) (235)
- An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2 (1987) (235)
- A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins (1995) (234)
- Identification of a bone sialoprotein receptor in osteosarcoma cells. (1988) (232)
- Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation (1988) (224)
- Tenascin mediates cell attachment through an RGD-dependent receptor (1989) (223)
- Targeting of albumin-embedded paclitaxel nanoparticles to tumors. (2009) (221)
- Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. (2003) (220)
- Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. (1977) (218)
- A Signaling Pathway from the α5β1 and αvβ3 Integrins That Elevatesbcl-2 Transcription* (2001) (215)
- Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers (1984) (215)
- A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. (2001) (213)
- Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. (2017) (210)
- Crystal structure of the tenth type III cell adhesion module of human fibronectin. (1994) (210)
- Fibroblast surface antigen: a new serum protein. (1973) (209)
- An Eph receptor regulates integrin activity through R-Ras. (1999) (209)
- Synthetic peptide with cell attachment activity of fibronectin. (1983) (207)
- Deposition of plasma fibronectin in tissues. (1981) (205)
- Common principles in cell adhesion. (1996) (204)
- Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. (1987) (204)
- Disappearance of a major cell‐type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by rous sarcoma virus (1974) (203)
- A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells (1976) (202)
- cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. (1986) (202)
- Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy (2018) (201)
- Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. (1987) (200)
- Transtumoral targeting enabled by a novel neuropilin-binding peptide (2012) (200)
- Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. (1989) (198)
- [27] Arginine-glycine-aspartic acid adhesion receptors (1987) (198)
- Complexing of fibronectin glycosaminoglycans and collagen. (1980) (197)
- Novel human serum protein from fibroblast plasma membrane (1974) (194)
- Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature (2002) (188)
- A high-throughput label-free nanoparticle analyser. (2011) (188)
- Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. (1990) (188)
- Placental alkaline phosphatase as a tumor marker for seminoma. (1982) (187)
- Laminin and fibronectin in cell adhesion: enhanced adhesion of cells from regenerating liver to laminin. (1981) (186)
- The Walter Herbert Lecture. Control of cell motility and tumour invasion by extracellular matrix interactions. (1992) (183)
- Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. (1989) (181)
- Subunit structure of a laminin-binding integrin and localization of its binding site on laminin. (1989) (180)
- X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. (2011) (180)
- The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin (1993) (179)
- Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. (1997) (176)
- NG2 proteoglycan-binding peptides target tumor neovasculature. (1999) (174)
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 (2012) (171)
- Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. (1985) (171)
- The RGD story: a personal account. (2003) (171)
- Fibronectin synthesis by epithelial crypt cells of rat small intestine. (1978) (169)
- Fibroblast surface antigen produced but not retained by virus- transformed human cells (1975) (168)
- β1 Integrins Are Critically Involved in Neutrophil Locomotion in Extravascular Tissue In Vivo (1998) (168)
- Membrane Dipeptidase Is the Receptor for a Lung-targeting Peptide Identified by in Vivo Phage Display* (1999) (166)
- Tumor-Penetrating Peptides (2013) (163)
- New Insights into "Permeability" as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics. (2017) (162)
- The cell attachment domain of fibronectin. Determination of the primary structure. (1982) (161)
- A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide (1992) (161)
- Targeting tumor vasculature with homing peptides from phage display. (2000) (160)
- A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences. (1987) (158)
- Immunolocalization of ciliary neuronotrophic factor in adult rat sciatic nerve (1992) (157)
- Studies of carcino‐fetal proteins. II. Biochemical comparison of α‐fetoprotein from human fetuses and patients with hepatocellular cancer (1971) (155)
- Integrin signaling and matrix assembly. (1996) (152)
- Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. (2009) (151)
- Solution structures and integrin binding activities of an RGD peptide with two isomers. (2001) (151)
- Extracellular matrices and cell adhesion. (1985) (151)
- Etchable plasmonic nanoparticle probes to image and quantify cellular internalization (2014) (149)
- Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA. (1985) (148)
- Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. (1987) (148)
- Vascular zip codes in angiogenesis and metastasis. (2004) (147)
- A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. (2000) (147)
- Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. (2000) (146)
- Concomitant loss of cell surface fibronectin and laminin from transformed rat kidney cells (1981) (145)
- Domain structure of vitronectin. Alignment of active sites. (1984) (143)
- Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. (2006) (143)
- Fibulin, a novel protein that interacts with the fibronectin receptor β subunit cytoplasmic domain (1989) (142)
- In vivo tumor cell targeting with "click" nanoparticles. (2008) (141)
- The versican C-type lectin domain recognizes the adhesion protein tenascin-R. (1995) (141)
- Nanoparticle-induced vascular blockade in human prostate cancer. (2010) (140)
- Alignment of biologically active domains in the fibronectin molecule. (1981) (139)
- De novo design of a tumor-penetrating peptide. (2013) (139)
- Proteolytic processing of endogenous and recombinant beta 4 integrin subunit (1992) (139)
- Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis. (1983) (139)
- Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. (1993) (138)
- An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. (1992) (137)
- An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability (2014) (137)
- Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells (1998) (136)
- Studies of carcino‐fetal proteins: Physical and chemical properties of human α‐fetoprotein (1971) (135)
- Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses (2000) (133)
- DISTRIBUTION OF FIBROBLAST SURFACE ANTIGEN (1974) (133)
- Cell attachment on replicas of SDS polyacrylamide gels reveals two adhesive plasma proteins (1982) (131)
- Codistribution of heparan sulfate proteoglycan, laminin, and fibronectin in the extracellular matrix of normal rat kidney cells and their coordinate absence in transformed cells (1982) (130)
- A polymeric form of fibronectin has antimetastatic effects against multiple tumor types (1996) (130)
- Fibronectin in cell adhesion and invasion (2004) (130)
- The Proteoglycan Lectin Domain Binds Sulfated Cell Surface Glycolipids and Promotes Cell Adhesion* (1999) (129)
- Interaction of vitronectin with collagen. (1986) (129)
- α Foetoprotein and serum albumin show sequence homology (1976) (127)
- A novel integrin beta subunit is associated with the vitronectin receptor alpha subunit (alpha v) in a human osteosarcoma cell line and is a substrate for protein kinase C. (1989) (126)
- Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. (2010) (125)
- How cancer spreads. (1996) (125)
- Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. (2000) (121)
- Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature (2001) (121)
- Genetic control of alpha-fetoprotein synthesis in the mouse (1977) (120)
- Integrins as signaling molecules and targets for tumor therapy. (1997) (118)
- Proteolytic actuation of nanoparticle self-assembly. (2006) (118)
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide (2017) (116)
- Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). (1976) (116)
- R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis (2005) (115)
- Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin. (1979) (115)
- A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries (2016) (114)
- Immunochemical and amino-terminal sequence comparison of two cytoadhesins indicates they contain similar or identical beta subunits and distinct alpha subunits. (1987) (114)
- Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins [published erratum appears in J Cell Biol 1992 Jul;118(1):217] (1992) (113)
- Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice (2011) (112)
- Integrins and vascular extracellular matrix assembly. (1997) (111)
- An alternative cytoplasmic domain of the integrin beta 3 subunit. (1989) (110)
- Radioimmunoassay of maternal serum alpha fetoprotein during pregnancy and delivery. (1972) (109)
- Cell spreading controls endoplasmic and nuclear calcium: A physical gene regulation pathway from the cell surface to the nucleus (2003) (109)
- Interaction of fibronectin with antibodies and collagen in radioimmunoassay. (1978) (108)
- iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. (2016) (108)
- Chemotherapy targeted to tumor vasculature. (1998) (107)
- Developmental changes in carbohydrate moiety of human alpha‐fetoprotein (1978) (105)
- Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. (2010) (104)
- Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. (1982) (103)
- Tumor-homing peptides as tools for targeted delivery of payloads to the placenta (2016) (103)
- Self‐Sealing Porous Silicon‐Calcium Silicate Core–Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain (2016) (103)
- A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. (2009) (102)
- Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice (2010) (101)
- Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus (2018) (100)
- cDNA sequences from the alpha subunit of the fibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide. (1986) (100)
- Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. (2009) (100)
- Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis. (1991) (99)
- α-Foetoprotein in Normal Human Serum (1972) (98)
- Serum α-Fetoprotein: Diagnostic Significance in Liver Disease (1974) (97)
- Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp- containing peptide overproduce the fibronectin receptor (1987) (97)
- Arginine-glycine-aspartic acid adhesion receptors. (1987) (97)
- A Mitochondrial Protein, Bit1, Mediates Apoptosis Regulated by Integrins and Groucho/TLE Corepressors (2004) (97)
- Gated Luminescence Imaging of Silicon Nanoparticles. (2015) (97)
- Laminin from rat yolk sac tumor: isolation, partial characterization, and comparison with mouse laminin. (1983) (96)
- Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. (1990) (96)
- Molecular Profiling of Heart Endothelial Cells (2005) (96)
- Isolation of a chondroitin sulfate proteoglycan from a rat yolk sac tumor and immunochemical demonstration of its cell surface localization. (1981) (95)
- Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy (2019) (95)
- Drug targeting to specific vascular sites. (2002) (95)
- Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display (2007) (94)
- Effect of a proteoglycan produced by rat tumor cells on their adhesion to fibronectin-collagen substrata. (1983) (93)
- Lymphangiogenesis and Cancer (2004) (93)
- The role of fibronectin in adhesion of metastatic melanoma cells to endothelial cells and their basal lamina. (1981) (91)
- CONGENITAL NEPHROTIC SYNDROME: PRENATAL DIAGNOSIS AND GENETIC COUNSELLING BY ESTIMATION OF AMNIOTIC-FLUID AND MATERNAL SERUM ALPHA-FETOPROTEIN (1976) (91)
- Tumor-Penetrating iRGD Peptide Inhibits Metastasis (2014) (90)
- Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. (2012) (90)
- Mapping of vascular ZIP codes by phage display. (2012) (90)
- Alpha fetoprotein in amniotic fluid: an index of gestational age. (1972) (90)
- The α5β1 Integrin Mediates Elimination of Amyloid-β Peptide and Protects Against Apoptosis (1998) (89)
- Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death. (1973) (88)
- Association of thrombin-antithrombin III complex with vitronectin in serum. (1985) (87)
- Integrins as Receptors for Extracellular Matrix (1991) (87)
- IMMUNOCHEMICAL AND COLLAGEN‐BINDING PROPERTIES OF FIBRONECTIN * (1978) (87)
- Stimulation of density‐inhibited cell cultures by insulin (1973) (86)
- Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis. (1990) (85)
- Adhesion of platelets to laminin in the absence of activation (1984) (84)
- A Mitochondrial Protein, Bit1, Mediates Apoptosis Regulated by Integrins and Groucho/TLE Corepressors (2005) (83)
- Interactions between chondroitin sulfate proteoglycan, fibronectin, and collagen. (1982) (83)
- Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts. (1984) (81)
- Two active sites with different characteristics in fibronectin (1979) (81)
- Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature (2009) (80)
- Alpha fetoprotein: Physiology and pathology during pregnancy and application to antenatal diagnosis (1973) (79)
- Immunofluorescent localization of fibronectin in the human kidney. (1979) (78)
- The cell attachment determinant in fibronectin (1985) (76)
- Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly. (1974) (76)
- Enhanced Baculovirus-Mediated Transduction of Human Cancer Cells by Tumor-Homing Peptides (2006) (76)
- Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta 1 integrin (1994) (76)
- Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti‐Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections (2017) (75)
- Laminin, a noncollagenous component of epithelial basement membranes synthesized by a rat yolk sac tumor. (1981) (75)
- Peptide Targeting of Tumor Lymph Vessels (2008) (75)
- Extracellular matrix/growth factor interactions. (1992) (74)
- Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain (2015) (74)
- 64Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic Plaque (2014) (74)
- L-arginine may mediate the therapeutic effects of low protein diets. (1995) (73)
- Peptides in cell adhesion research. (1994) (72)
- Lymphatic zip codes in premalignant lesions and tumors. (2006) (71)
- Activated Src Oncogene Phosphorylates R-Ras and Suppresses Integrin Activity* (2002) (71)
- Molecular changes in the vasculature of injured tissues. (2007) (71)
- Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth. (2017) (71)
- Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. (1990) (70)
- Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. (1979) (70)
- The alpha 5 beta 1 fibronectin receptor. Characterization of the alpha 5 gene promoter. (1991) (69)
- Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity (2003) (69)
- Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric development (1996) (69)
- Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. (2003) (68)
- Molecular cloning of the cDNA encoding human laminin A chain. (1991) (67)
- Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. (2013) (67)
- Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. (1993) (67)
- Alpha‐fetoprotein: Immunochemical Purification and Chemical Properties. Expression in Normal State and in Malignant and non‐Malignant Liver Disease (1974) (67)
- Serglycin‐binding proteins in activated macrophages and platelets (1996) (67)
- Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy (2017) (65)
- Enhanced Magnetic Resonance Contrast of Fe3O4 Nanoparticles Trapped in a Porous Silicon Nanoparticle Host (2011) (65)
- Identification of Gal(β1–3)GalNAc bearing glycoproteins at the nodes of ranvier in peripheral nerve (1994) (65)
- New p32/gC1qR Ligands for Targeted Tumor Drug Delivery (2016) (65)
- α-FETOPROTEIN IN NORMAL AND PREGNANCY SERA (1972) (65)
- Differential expression of alpha-fetoprotein and gamma-glutamyltranspeptidase in chemical and spontaneous hepatocarcinogenesis. (1979) (65)
- Selection of phage-displayed peptides on live adherent cells in microfluidic channels (2011) (64)
- Affinity of IgM and IgG antibodies. (1970) (64)
- Vascular homing peptides with cell-penetrating properties. (2005) (64)
- Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. (2011) (64)
- Alpha-fetoprotein in Abortion (1972) (64)
- Mutation of the Protein Kinase C Phosphorylation Site on Rat α1 Na+,K+-ATPase Alters Regulation of Intracellular Na+ and pH and Influences Cell Shape and Adhesiveness* (1997) (63)
- Primary structure of a mouse mastocytoma proteoglycan core protein. (1989) (63)
- Distribution of fibronectin on clonal cell lines of a rat mammary adenocarcinoma growing in vitro and in vivo at primary and metastatic sites. (1981) (63)
- The neurite-promoting domain of human laminin promotes attachment and induces characteristic morphology in non-neuronal cells. (1988) (63)
- Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. (1995) (62)
- Porous silicon-graphene oxide core-shell nanoparticles for targeted delivery of siRNA to the injured brain. (2016) (61)
- Foetoneonatal oestradiol-binding protein in mouse brain cytosol is α foetoprotein (1976) (61)
- Extracellular matrix components (1994) (60)
- Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation (2007) (60)
- Similarity of fibronectins isolated from human plasma and spent fibroblast culture medium (1977) (60)
- Crystal Structure of a Human Peptidyl-tRNA Hydrolase Reveals a New Fold and Suggests Basis for a Bifunctional Activity* (2004) (60)
- α5β1 integrin stimulates Bcl‐2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin‐dependent protein kinase IV (2005) (60)
- Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract (1975) (60)
- A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis. (2015) (59)
- Laminin-like glycoproteins in extracellular matrix of endodermal cells. (1980) (58)
- Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: Comparison of T1, T2*, and synergistic T1 − T2* contrast mechanisms (2011) (58)
- R-Ras Contains a Proline-rich Site That Binds to SH3 Domains and Is Required for Integrin Activation by R-Ras* (2000) (58)
- Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. (2012) (58)
- MITOGENIC EFFECT BY LIPOPOLYSACCHARIDE AND POKEWEED LECTIN ON DENSITY-INHIBITED CHICK EMBRYO FIBROBLASTS (1973) (57)
- Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy (2016) (56)
- A Novel Matrix Attachment Region DNA Binding Motif Identified Using a Random Phage Peptide Library (*) (1995) (56)
- Composite Porous Silicon-Silver Nanoparticles as Theranostic Antibacterial Agents. (2016) (56)
- Tumor‐Targeted Multimodal Optical Imaging with Versatile Cadmium‐Free Quantum Dots (2016) (56)
- Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. (2005) (54)
- Betaglycan has multiple binding sites for transforming growth factor-beta 1. (1996) (54)
- [Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver]. (1972) (54)
- Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. (2001) (53)
- Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. (2012) (53)
- Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy. (2019) (52)
- Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides (2015) (52)
- In vivo cation exchange in quantum dots for tumor-specific imaging (2017) (51)
- Immunological crossreaction between alpha-fetoprotein and albumin. (1976) (51)
- Demonstration of fibronectin in human cerebrospinal fluid. (1978) (51)
- β1C Integrin in Epithelial Cells Correlates with a Nonproliferative Phenotype : Forced Expression of β1C Inhibits Prostate Epithelial Cell Proliferation (1998) (51)
- Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide‐guided pro‐apoptotic nanoparticles (2017) (50)
- Polypeptides of a glycoprotein antigen (SF) present in serum and surface of normal but not of transformed chicken fibroblasts. (1975) (50)
- A neuroectoderm-associated ganglioside participates in fibronectin receptor-mediated adhesion of germinal cells to fibronectin. (1989) (50)
- Application of a proapoptotic peptide to intratumorally spreading cancer therapy. (2013) (50)
- BR140, a novel zinc-finger protein with homology to the TAF250 subunit of TFIID. (1994) (50)
- Synthetic surfaces for human embryonic stem cell culture. (2010) (50)
- A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity. (2014) (49)
- Structure of fibronectin and its fragments in electron microscopy. (1982) (49)
- Identification from cDNA of the precursor form of a chondroitin sulfate proteoglycan core protein. (1986) (48)
- Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide‐Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNA (2019) (48)
- Selection of Peptides Binding to the a 5 pl Integrin from Phage Display Library (2001) (47)
- Characterization and use of an allotype-specific monoclonal antibody to placental alkaline phosphatase in the study of cancer-related phosphatase polymorphism. (1982) (47)
- Peptide-directed highly selective targeting of pulmonary arterial hypertension. (2011) (47)
- Monoclonal antibodies to human alphafetoprotein (1980) (47)
- Comparative studies on amniotic fluid and plasma fibronectins. (1981) (47)
- Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease. (1972) (46)
- Butyrate restores fibronectin at cell surface of transformed cells. (1980) (45)
- Fibronectin: a molecule with remarkable structural and functional diversity (1982) (45)
- Expression of fibronectin and laminin in the rat liver after partial hepatectomy, during carcinogenesis, and in transplantable hepatocellular carcinomas. (1982) (44)
- Peptide-guided nanoparticles for glioblastoma targeting. (2019) (44)
- Structure of the carbohydrate units of human amniotic fluid fibronectin. (1985) (43)
- Urokinase-controlled tumor penetrating peptide. (2016) (43)
- Anoikis effector Bit1 negatively regulates Erk activity (2008) (43)
- Subtypes of human ABO blood groups and subtype-specific antibodies. (1969) (43)
- Isolation of the fundamental polypeptide subunits of biological membranes. (1970) (42)
- A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension. (2014) (42)
- Alpha-fetoprotein in antenatal diagnosis. (1973) (42)
- Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease (2017) (42)
- alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV. (2005) (42)
- Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. (2009) (42)
- Carbohydrate structure of the concanavalin A molecular variants of alpha-fetoprotein. (1982) (41)
- A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans (1993) (41)
- Effect of dextran sulfate on fibronectin‐collagen interaction (1979) (40)
- High level of alpha‐fetoprotein in sera of adult mice (1973) (39)
- Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis (2011) (38)
- Protein Kinase D Is a Positive Regulator of Bit1 Apoptotic Function* (2008) (38)
- The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies* (2010) (38)
- Fibroblast surface antigen (SF): THE external glycoprotein lost in proteolytic stimulation and malignant transformation (1976) (37)
- Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. (1976) (37)
- Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. (2008) (37)
- alpha-fetoprotein binding specificity for arachidonate, bilirubin, docosahexaenoate, and palmitate. A spin label study. (1980) (36)
- Molecular and biological interactions of fibronectin. (1982) (36)
- Targeted Antiscarring Therapy for Tissue Injuries. (2013) (36)
- Rabbit -fetoprotein: immunochemical purification and partial characterization. (1973) (35)
- Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis. (1979) (34)
- Alpha-fetoproteins produced by the yolk sac and the liver are glycosylated differently. (1978) (34)
- Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture. (1985) (33)
- Superfibronectin, a Multimeric Form of Fibronectin, Increases HIV Infection of Primary CD4+ T Lymphocytes1 (2000) (33)
- Rabbit alpha‐fetoprotein: normal levels and breakage tolerance with haptenated homologous alpha‐fetoprotein (1975) (33)
- Purification and characterization of vitronectin. (1987) (33)
- TLE1 Is an Anoikis Regulator and Is Downregulated by Bit1 in Breast Cancer Cells (2012) (33)
- Integrins and vascular extracellular matrix assembly. (1997) (32)
- Metastasis of Tumor Cells Is Enhanced by Downregulation of Bit1 (2011) (32)
- Quantity and accessibility for specific targeting of receptors in tumours (2014) (32)
- Alphafetoprotein as a Marker for Early Events and Carcinoma Development During Chemical Hepatocarcinogenesis (1983) (31)
- Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver. (1973) (31)
- Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes. (2016) (31)
- Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles. (2012) (31)
- Reprogramming Human Retinal Pigmented Epithelial Cells to Neurons Using Recombinant Proteins (2014) (31)
- Hypothesis: when is a seminoma not a seminoma? (1981) (31)
- Fibronectin and its alpha 5 beta 1 integrin receptor in malignancy. (1994) (30)
- Radioimmunoassay of alpha‐fetoprotein: A contribution to the diagnosis of choriocarcinoma and hydatidiform mole (1972) (30)
- Tissue targeting with phage peptide libraries. (1996) (30)
- Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. (2004) (30)
- Cell adhesion and tumor metastasis. (1994) (30)
- Alpha‐Fetoprotein in Rh‐Immunized Pregnancies (1973) (30)
- Selection strategies for anticancer antibody discovery: searching off the beaten path. (2015) (30)
- Cell adhesion: New way to activate caspases (1999) (29)
- Molecular cloning and nucleotide sequence of a cDNA clone coding for the cell attachment domain in human fibronectin. (1983) (29)
- Differentiation of fetal liver cells in vitro. (1981) (29)
- Serum Concentration of Human Placental Lactogenic Hormone (HPL) in Pregnancy Complications (1970) (29)
- Radioimmunoassay of oxytocin in amniotic fluid, fetal urine, and meconium during late pregnancy and delivery. (1972) (28)
- Cell adhesive, protein binding, and antigenic properties of laminin. (1983) (28)
- Evolution of the fibronectin gene. Exon structure of cell attachment domain. (1986) (28)
- The human leukocyte-adhesion ligand, intercellular-adhesion molecule 2. Expression and characterization of the protein. (1991) (28)
- Origin of Proteins in Amniotic Fluid (1966) (27)
- Tracking the Fate of Porous Silicon Nanoparticles Delivering a Peptide Payload by Intrinsic Photoluminescence Lifetime (2018) (27)
- Bit1 in anoikis resistance and tumor metastasis. (2013) (26)
- Targeted silver nanoparticles for ratiometric cell phenotyping. (2016) (26)
- Antigen‐Antibody Precipitates and Immunoadsorbents. Application to Purification of Alpha‐Foetoprotein (1976) (26)
- Tumor‐specific macrophage targeting through recognition of retinoid X receptor beta (2019) (25)
- Generation of a multi‐functional, target organ‐specific, anti‐fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin (2018) (24)
- Fibroblast surface protein (1978) (24)
- Radioimmunoassay of capsular polysaccharide antigens of groups A and C meningococci and Haemophilus influenzae type b in cerebrospinal fluid. (1977) (24)
- [Possibilities and limitations of CEA-tests]. (1975) (24)
- Binding of bilirubin by bovine and human α-fetoprotein (1979) (23)
- Affinity chromatography of collagen on collagen-binding fragments of fibronectin. (1981) (23)
- Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies (2013) (23)
- Antigen‐Antibody Interaction, Antibody Affinity, and Dissociation of Immune Complexes (1976) (23)
- Letter: Antenatal diagnosis of spina bifida. (1973) (23)
- Fibronectin from human germ‐cell tumors resembles amniotic fluid fibronectin (1981) (22)
- Antiangiogenics meet nanotechnology. (2002) (22)
- High affinity of alpha-foetoprotein for arachidonate and other fatty acids. (1980) (22)
- Identification and isolation of a foetoprotein in the chicken. (1974) (21)
- Immunochromatography on insolubilized antibodies of very low affinity: application to immunoadsorbence of bovine alpha-fetoprotein. (1978) (21)
- Serum alpha-fetoprotein: diagnostic significance in liver disease. (1974) (21)
- Breakage of tolerance to α foetoprotein in monkeys (1975) (21)
- Carcinoembryonic antigen-like substance in gastric juice. (1976) (21)
- Clonal tumorigenic endodermal cell lines producing basement membrane components. (1984) (21)
- Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein. (1987) (20)
- The anti-angiogenic peptide anginex disrupts the cell membrane. (2006) (20)
- Expression of the major group‐specific antigen (GS‐A) of avian type‐C viruses in normal chicken cells and tissues (1973) (20)
- A 30 kD sulfated extracellular matrix protein immunologically crossreactive with vitronectin. (1993) (20)
- Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. (2013) (20)
- ALPHA FETOPROTEIN LEVELS IN NEONATAL HYPERBILIRUBINAEMIA (1980) (20)
- Gene expression of the chondroitin sulfate proteoglycan core protein PG19 (1987) (19)
- Immunological evidence for two distinct chondroitin sulfate proteoglycan core proteins: differential expression in cartilage matrix deficient mice. (1983) (19)
- Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque. (2016) (19)
- Nucleolin expressed at the cell surface is a marker of endothelial cells in tumor blood vessels (2003) (19)
- Erratum: Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma (Proc Natl Acad Sci USA (2011) 108 (17450-17455) DOI: 10.1073/pnas.1114518108) (2014) (19)
- iRGD‐Liposomes Enhance Tumor Delivery and Therapeutic Efficacy of Antisense Oligonucleotide Drugs against Primary Prostate Cancer and Bone Metastasis (2021) (19)
- Connections count in cell migration (1999) (18)
- Detection of circulating tumor antigens (1977) (18)
- Tumor-penetrating therapy for β5 integrin-rich pancreas cancer (2021) (18)
- Molecular interactions of fibronectin. (1980) (18)
- Peptides in cell adhesion: powerful tools for the study of integrin-ligand interactions. (1996) (17)
- Monkey antisera with increased specificity to carcinoembryonic antigen (CEA) (1976) (17)
- Effect of specific immunotherapy with preimmunization against alpha-fetoprotein on a mouse transplantable hepatoma. (1977) (17)
- Integrin a 2 b 1 (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue (17)
- Immune‐mediated ECM depletion improves tumour perfusion and payload delivery (2019) (17)
- Immunoadsorbents in Protein Purification (1976) (16)
- Recombinant Decorin Fusion Protein Attenuates Murine Abdominal Aortic Aneurysm Formation and Rupture (2017) (16)
- Alpha-fetoprotein in normal and pregnancy sera. (1972) (16)
- Studies of carcino-fetal proteins: physical and chemical properties of human alpha-fetoprotein. (1971) (16)
- Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing (2012) (16)
- An adhesion variant of the MG-63 osteosarcoma cell line displays an osteoblast-like phenotype. (1988) (16)
- gamma-Glutamyl transpeptidase in human amniotic fluid and in fetal tissues. (1983) (16)
- An alternative cytoplasmic domain of the integrin f83 subunit (15)
- Isolation from human gastric juice of an antigen closely related to the carcinoembryonic antigen (1976) (15)
- Crystals of the cell-binding module of fibronectin obtained from a series of recombinant fragments differing in length. (1994) (15)
- Identification of endothelial genes up-regulated in vivo. (2005) (14)
- In silico molecular engineering for a targeted replacement in a tumor-homing peptide. (2009) (14)
- Human chromosome 11 is syntenic with human specific fibronectin production in human x mouse cell hybrids. (1980) (14)
- Unfolded transferrin polypeptide chain is immunologically crossreactive with similar derivatives of serum albumin and alpha-fetoprotein. (1982) (14)
- Role of TGF-beta 1 in experimental glomerulonephritis. (1991) (14)
- Extracellular Matrix in the Regulation of Cellular Functions (1990) (14)
- Clot-targeted micellar formulation improves anticoagulation efficacy of bivalirudin. (2014) (14)
- A Signaling Pathway from the a5b1 and avb3 Integrins That Elevates bcl-2 Transcription* (2001) (14)
- alpha foetoprotein and serum albumin show sequence homology. (1976) (13)
- Isolation and partial characterization of a rat hepatoma heparan sulfate proteoglycan. (1982) (13)
- Alpha fetoprotein: structure and expression in man and inbred mouse strains under normal conditions and liver injury. (1974) (13)
- Radioimmunoassay of avian RNA tumor virus group-specific antigen. (1973) (12)
- Antibodies against avian GS antigen in chickens infected naturally and experimentally with avian RNA tumor viruses (1973) (12)
- Specific anti‐fibroblast cytotoxicity of antibodies to fibroblast surface antigen (1976) (12)
- Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites (2013) (11)
- Binding of fibronectin to actin is inhibited by gelatin. (1981) (11)
- Early increase of serum alpha‐fetoprotein in spontaneous hepatocarcinogenesis in mice (1978) (10)
- Genetical evidence for maternal origin of amniotic fluid proteins. (1966) (10)
- A monkey antigen crossreacting with carcinoembryonic antigen, CEA. (1976) (10)
- Antigenic differences in nuclear proteins of normal liver and hepatoma (1977) (10)
- Alphafetoprotein is not a component of the 8 S estradiol receptor from the immature mouse uterus or brain (1977) (10)
- Immunological studies in human placental proteins and the purification of human placental lactogen. (1965) (10)
- Immunochemical properties of alpha-fetoprotein (AFP) and antibodies to autologous AFP. (1978) (9)
- Titelbild: Proteolytic Actuation of Nanoparticle Self‐Assembly (Angew. Chem. 19/2006) (2006) (9)
- Versatile mechanisms of cell adhesion. (1988) (9)
- Alpha fetoprotein in uterine hemorrhage during pregnancy and delivery. (1972) (9)
- EFFECT OF CHEMICAL MODIFICATION ON THE IMMUNO‐GENICITY OF HOMOLOGOUS α‐FETOPROTEIN * (1975) (9)
- Foetoneonatal oestradiol-binding protein in mouse brain cytosol is alpha foetoprotein. (1976) (9)
- Cloning of Mouse Integrin Otv eDNA and Role of the OLv-related Matrix Receptors in Metanephric Development (2002) (9)
- Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections. (2021) (9)
- Ratiometric in vivo auditioning of targeted silver nanoparticles. (2017) (9)
- Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment (2017) (8)
- Radioimmunoassay of the group-specific antigen in detection of avian leukosis virus infection. (1974) (8)
- A Weak B Blood Group (Bv) in a Finnish Family (1967) (8)
- Silver Nanocarriers Targeted with a CendR Peptide Potentiate the Cytotoxic Activity of an Anticancer Drug (2020) (8)
- Proteolytic Processing of Endogenous and Recombinant/34 Integrin Subunit (2002) (8)
- TRANSFORMING GROWTH FACTOR BETA REGULATES PRODUCTION OFPROTEOGLYCANS BY MESANGIAL CELLS (1990) (8)
- Targeting tumor associated macrophages using clodronate-loaded PLGA nanoparticles (2010) (8)
- Binding of bilirubin by bovine and human alpha-fetoprotein. (1979) (8)
- Mouse Alpha‐fetoprotein: Genetic Studies (1978) (8)
- Immunological purification and chemical characterization of the group‐specific proteins (Gc) from human serum (1971) (7)
- [1] Radioimmunoassay of α-fetoprotein with polyclonal and monoclonal antibodies (1982) (7)
- Vascular histomolecular analysis by sequential endoarterial biopsy in a shunt model of pulmonary hypertension (2013) (7)
- Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier. (2017) (7)
- Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions * (7)
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4 (2012) (6)
- Increasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment (2015) (6)
- as Modulators of Growth Factor Activities (1991) (6)
- Searching for a molecular address in the brain. (1996) (6)
- Correction: RuGli cell line not of human origin. (1989) (6)
- CEA and CEA-like activity in gastric cancer. (1976) (6)
- Direct tissue visualization of normal cross-reacting antigen in neoplastic granulocytes. (1980) (6)
- Concurrent modulation of cell surface fibronectin and adhesion to fibronectin in hepatoma cells. (1983) (6)
- Ovarian Cancer Oncogene Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the (2012) (6)
- Studies on the molecular basis of Gc polymorphism. (1967) (6)
- Drug Identification through in vivo Screening of Chemical Libraries (2004) (5)
- Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein. (1976) (5)
- NG 2 Proteoglycan-binding Peptides Target Tumor Neovasculature 1 (1999) (5)
- Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. (1998) (5)
- Identity of Transferrin DChi from the Chinese and from the Finns (1968) (5)
- Conformational flexibility and crystallization of tandemly linked type III modules of human fibronectin (1996) (5)
- Studies on the purification of the human serum group specific component. (1966) (5)
- Molecular cloning of proteoglycan core proteins. (1986) (5)
- Selective Delivery to Vascular Addresses: In Vivo Applications of Cell-Type-Specific Cell-Penetrating Peptides (2006) (5)
- A single-chain integrin? [1] (1991) (5)
- 85 FIBRONECTIN (FN) AND GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) EXPRESSION IN HUMAN ANAPLASTIC GLIOMAS (HG1) GROWN IN ATHYMIC “NUDE” MICE (1980) (5)
- An Eph receptor regulates integrin activity through (1999) (5)
- Cover Picture: Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging (Adv. Mater. 9/2008) (2008) (4)
- Isolation and biochemical properties of alpha-fetoprotein. (1978) (4)
- Inheritance and Genetic Linkage of Gc and Tf Groups (1967) (4)
- The a 5 b 1 Integrin Mediates Elimination of Amyloid-b Peptide and Protects Against Apoptosis (1998) (4)
- Enhanced magnetic resonance contrast of iron oxide nanoparticles embedded in a porous silicon nanoparticle host (2013) (4)
- Differences in the nuclear proteins of normal and malignant liver cells. (1980) (4)
- Cell-matrix interactions in development and neoplasia. (1981) (4)
- The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. (2011) (4)
- iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis (2021) (4)
- Silicon Nanoparticles: Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti‐Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections (Adv. Mater. 35/2017) (2017) (4)
- Monoclonal antiodies to human alphafetoprotein. (1980) (3)
- Molecular ZIP codes in targeted drug delivery (2022) (3)
- Abstract 5406: The CendR pathway: A novel cell penetration and transcytosis pathway regulated by nutrient availability (2014) (3)
- b 1 C Integrin in Epithelial Cells Correlates with a Nonproliferative Phenotype Forced Expression of b 1 C Inhibits Prostate Epithelial Cell Proliferation (1998) (3)
- Protein Kinase D Is a Positive Regulator of Bit 1 Apoptotic Function * (2008) (3)
- TLE 1 is an anoikis regulator and is downregulated by Bit 1 in breast cancer cells (2012) (3)
- Harvesting molecular diversity--biology's new commodity. (1997) (3)
- Further polymorphism in Gc system. Evidence for the occurrence of subgroups. (1965) (3)
- Alpha-fetoprotein in normal and pregnancy sera. [Letter] (1972) (3)
- Detection of an organ specific protein in the human thymus. (1966) (3)
- Purification of the Carcinoembryonic Antigen (CEA) with Immunoadsorbents (1976) (3)
- Correction for Fogal et al., “Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation” (2017) (2)
- The a 5 ( 81 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression (2005) (2)
- Tumor Cell Targeting with “ Click ” Nanoparticles (2008) (2)
- In vivo selection of tumor-specific antibodies (2013) (2)
- Vascular Zip Codes and Nanoparticle Targeting (2006) (2)
- Low frequency of genetic factors (gm(s) and Di(a) in Finland. (1969) (2)
- SOLUTION STRUCTURE OF AN RGD PEPTIDE ISOMER-A (2001) (2)
- CRITICAL ISSU-ES IN TUMOR MICROCIRCULATION, ANGIOGENESIS AND METASTASIS: BIOLOGICAL SIGNIFICANCE AND CLINICAL RELEVANCE (1993) (2)
- Reflections on Integrins-Past, Present, and Future: The Albert Lasker Basic Medical Research Award. (2022) (2)
- iRGD in combination with IL-2 reprograms tumor immunosuppression. (2019) (2)
- Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain (2015) (2)
- Optimization of Peptide-Tagged Cationic Lipid Nanoparticles for Targeted Gene Delivery (2016) (2)
- FIBRC)NECTIN AND ITS RECEPTORS (1988) (2)
- Role of TGF‐β1 in Experimental Glomerulonephritis (2007) (2)
- Regular inheritance of Gc groups in 169 families and 184 mother-child combinations. (1969) (1)
- Monoclonal antibodies in immunoassays (1982) (1)
- Determination of the Gc groups by disc electrophoresis. (1966) (1)
- A single-chain integrin? (1991) (1)
- Perspectives Series: Cell Adhesion in Vascular Biology Integrins and Vascular Extracellular Matrix Assembly (1997) (1)
- A tumor homing peptide with potential as a pharmaceutical for cancer treatment and imaging (2008) (1)
- Optimization of Iron Oxide Nanoparticles Detection using Ultrashort TE Imaging (2009) (1)
- Increased vascular permeability in R-Ras knockout mice with hypoxia-induced retinopathy and a lack of R-Ras expression in human diabetic retinal neovasculature (2015) (1)
- Live Cell Imaging with Rab-Gtpases Elucidates Intracellular Pathways of RGD and iRGD Tagged Cationic Lipid-DNA Nanoparticles (2014) (1)
- Cover Picture: Proteolytic Actuation of Nanoparticle Self‐Assembly (Angew. Chem. Int. Ed. 19/2006) (2006) (1)
- Abstract NG03: A novel endocytic and intercellular transport pathway for drug delivery across blood vessels and into nutrient-deprived tumor cells (2015) (1)
- Regulation of TGF-Beta expression in vivo in experimental liver fibrosis (1995) (1)
- Radioimmunoassay of alpha-fetoprotein with polyclonal and monoclonal antibodies. (1982) (1)
- Breakage of tolerance to alpha foetoprotein in monkeys. (1975) (1)
- Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with TGF-β activity (1994) (1)
- Abstract 1106: Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2 (2019) (1)
- DEPLETION OF TUMOR-ASSOCIATED MACROPHAGES WITH CLODRONATE-LOADED PLGA NANOPARTICLES (2013) (1)
- Abstract 4962: TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells (2012) (1)
- 158 POSTER Targeting bladder tumor cells in vivo and in the urine by a peptide identified using phage display (2006) (1)
- Bibliography on human reproduction family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region: sterilization-male and female (including review of current status). (1976) (1)
- Probing Tumor Microenvironment with In Vivo Phage Display (2013) (1)
- Abstract LB-102: A tumor-specific tissue penetrating peptide inhibits metastasis (2014) (1)
- Versatility of Cell Adhesion Mechanisms (1989) (1)
- Exogenous fibronectin is not required for organogenesis in vitro (1983) (1)
- Inhibitor of cell transfer comprising synthetic peptide (1989) (0)
- [Serological investigation in paternity cases]. (1968) (0)
- DOD W 81 XWH-061-0482 Targeting Therapy-Resistant Tumor Vessels PI : (2007) (0)
- The α5β1 integrin in tumour suppression : Metastases (1994) (0)
- Magnetic Nanoworms for in vivo Tumor Targeting (2006) (0)
- 2. Structural Features of Alphafetoprotein in Relation to its Function and Diagnostic Application (1981) (0)
- Assay using synthetic peptide (1996) (0)
- Human Genetic Mutant Cell Repository Reports Index (1980) (0)
- 455. Targeting of a Non-Human Coronavirus to Human Tumor Cells by Using a Bispecific Single-Chain Antibody (2003) (0)
- A process for the manufacture of stabilized cell adhesion peptides conformationnell (1988) (0)
- Peptides homing for lymphgefässtumor and their use (2002) (0)
- Syndecan 4Heparan Sulfate Proteoglycan Isa Selectively Enriched andWidespread Focal Adhesion Component (1994) (0)
- Correction (1961) (0)
- Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy (2018) (0)
- Targeting Nanoparticle Probes to Differentiating Stem Cells (2008) (0)
- In vivo phage display uncovers retinal endothelium-homing motifs in normal and optic nerve crushed eyes. (2015) (0)
- Vascular Smooth Muscle Cells from Injured Rat Aortas Display Elevated Matrix Production Associated with Transforming Growth Factor-f3 Activity (2007) (0)
- Nanoparticle-to-Nanoparticle Signaling for Amplified Tumor Targeting and Therapy (2009) (0)
- IDENTIFICATION OF DYSREGULATED MICRORNAS IN A SURGICAL SHUNT MODEL OF PULMONARY ARTERIAL HYPERTENSION: DISCOVERY BY ENDOARTERIAL BIOPSY (2009) (0)
- A polypeptide-polymer conjugates that are active in wound healing (1991) (0)
- Chaiman's Summing‐Up (2007) (0)
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide (2017) (0)
- Recombinant Decorin Fusion Protein Attenuates Murine Abdominal Aortic Aneurysm Formation and Rupture (2017) (0)
- S5.1 Regulation of growth factor activities by proteoglycans (1993) (0)
- Nutrient-Dependency of CendR Endocytosis Pathway is Uniquely Regulated by Mutant Kras and Targetable (2021) (0)
- Use of decorin or biglycan for the preparation of a medicament for the treatment of diabetes-related conditions (1992) (0)
- Editorial Board (2013) (0)
- Mother Ships” for Nano-Diagnostics and Nano-Therapeutics (2006) (0)
- [Quantification of serum proteins by immunodiffusion]. (1968) (0)
- Suppression de la proliferation de cellules a l'aide de decorine (1989) (0)
- Immunological crossreaction between alpha-fetoprotein and albumin ( carcinoembryonic antigens / amino acid sequence homology / fetal serum / immunological properties of unfolded polypeptide chains ) (0)
- Title Tumor-Targeting , MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy (2019) (0)
- ENGINEERING COMPOUNDS TARGETED TO VASCULAR ZIP CODES (2008) (0)
- Evaluation of a Peptide-Coated Nanoparticle as a Potential Therapy Against Preclinical Brain Metastatic Breast Cancer (2013) (0)
- Chapter 26: Targeting of Albumin‒Embedded Paclitaxel Nanoparticles to Tumors (2017) (0)
- Abstract PR5: Treatment of ovarian cancer with targeted tumor-penetrating siRNA nanocomplexes (2012) (0)
- Abstract 9768: Cr(nMe)eka-Conjugated Micellar Formulation Improves Anticoagulation Efficacy of Bivalirudin (2014) (0)
- Targeting Breast Cancer Vasculature (2003) (0)
- Effect of chemical modification on the immunogenicity of homologous alpha-fetoprotein. (1975) (0)
- Abstract 705: In vivo audition of tumor homing peptides using high-throughput sequencing and q-PCR (2014) (0)
- Abstract IA12: Stromal cells in the targeting and transport of tumor-penetrating peptides (2016) (0)
- Polypeptide-polymer conjugates having a wound healing effect (1989) (0)
- olla, CA 92037; and Molecular Pathology Graduate Program, (2016) (0)
- Alpha‐Fetoprotein (1978) (0)
- Supramolecular nanoparticles that target phosphatidylinositol-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy (2013) (0)
- Subject Index Vol. 28, 1980 (1980) (0)
- Molecular Profiling of Heart Endothelial Cells Molecular Cardiology (2005) (0)
- [PATERNITY INDEX BASED ON BLOOD GROUP EXAMINATION]. (1964) (0)
- Molecules that home to selected organs or tissues in vivo (1996) (0)
- Abstract 4504: Urokinase plasminogen activator-dependent tumor penetrating peptide (2014) (0)
- Purification and some properties of rabbit serum grou-specific protein. (1970) (0)
- MicroRNAs MiR-520d And Let-7d Are Dysregulated In An Animal Model Of Pulmonary Arterial Hypertension: Detection By Endoarterial Biopsy (2010) (0)
- Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease (2018) (0)
- Abstract 5526: Deciphering the basis of CendR-mediated penetration into tumors (2015) (0)
- Systemically administered wound-homing peptide accelerates wound healing (2013) (0)
- [Alpha-fetoprotein--a carcinoembryonal antigen]. (1972) (0)
- Inhibiteurs de facteurs regulateurs cellulaires et procedes de prevention ou de reduction de la formation de cicatrices (1992) (0)
- Inhibition of transforming growth factor for the prevention of the accumulation of extracellular matrix (1990) (0)
- Abstract C33: N-terminal fragment of Bit1 apoptotic protein induces autophagy in tumor cells (2011) (0)
- Abstract 3258: Targeting premalignant lesions for early breast cancer detection and intervention (2014) (0)
- Abstract 19366: NG2 Ablation Aggravates Obesity and Hyperlipidemia but Reduces Atherogenesis (2012) (0)
- Peptide and Protects Against Apoptosis (1998) (0)
- Abstract 487: Systemic Administration of Target-Seeking, Vessel Penetrating Recombinant Decorin Fusion Protein, Car-DCN, Reduces Severity of Abdominal Aortic Aneurysm in Mice (2017) (0)
- Abstract 3703: Nanoparticle-induced targeted pro-apoptotic peptide in glioblastoma (2010) (0)
- Abstract LB-062: Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles (2017) (0)
- Drug Identification through in vivo Screening of Chemical Libraries (2004) (0)
- Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus (2018) (0)
- Polypeptides having fibronectin binding positions as a modulator of matrixes compilation (1993) (0)
- STAGE-SPECIFIC PHARMACOGENOMICS IN A SURGICAL SHUNT MODEL OF PULMONARY ARTERIAL HYPERTENSION: ANALYSIS BY ENDOARTERIAL BIOPSY (2008) (0)
- Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease (2017) (0)
- Hybrid Nanotechnologies for Detection and Synergistic Therapies for Breast Cancer (2012) (0)
- Editorial Board (1981) (0)
- Tumor-penetrating drug delivery for cancer therapy. (2010) (0)
- Cell Cycle , Cell Death , and Senescence TLE 1 Is an Anoikis Regulator and Is Downregulated by Bit 1 in Breast Cancer Cells (2012) (0)
- Abstract 1343: P32-targeting TT1 peptide delivers nanoparticles to intracranial glioblastomas (2016) (0)
- Human endothelial cells express vitronectin and fibronectin receptor alpha chain but not IIB mRNAs (1987) (0)
- Contents, Vol. 28, 1980 (1980) (0)
- Polypeptide-polymer conjugates for treating wounds. (1989) (0)
- Systems Nanotechnology to Amplify Tumor Targeting (2012) (0)
- In vivo cation exchange in quantum dots for tumor-specific imaging (2017) (0)
- United States Patent ( 19 ) Charo et al . 54 PEPTIDES DERIVED FROM GPA ( 75 ) Inventors : Israel (2017) (0)
- Radioimmunoassay ofcapsular polysaccharide antigens ofgroupsA andCmeningococci and Haemophilus influenzae typebincerebrospinal fluid (1977) (0)
- T Lymphocytes + Primary CD4 Fibronectin, Increases HIV Infection of Superfibronectin, a Multimeric Form of (2000) (0)
- United States Patent ( 19 ) Ruoslahti et al . 54 ADHESION RECEPTOR FOR LAMININ AND ITS USE (2017) (0)
- Abstract 5090: The role of p32 in brain metastasis (2010) (0)
- Correction: RuGli Cell Line Not of Human Origin (1989) (0)
- Transferrin system in paternity cases. An immunological verification test for heterozygosity. (1967) (0)
- Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA ( extracellular matrix / cell adhesion / glycosylation ) (2003) (0)
- Monoclonal antibodies in radioimmunoassay of alphafetoprotein. Abstr. (1980) (0)
- MEASUREMENT OF SOLUBLE BLOOD GROUP SUBSTANCES USING LECTINS. (1963) (0)
- Vascular Pharmacotranscriptomics Via Endoarterial Biopsy in a Model of Pulmonary Arterial Hypertension (PAH). (2009) (0)
- Antenatal diagnosis of spina bifida. [Letter] (1973) (0)
- TheKidneyandIntravascular Coagulation inMyelomatosis (1974) (0)
- Protein kinase D is a positive regulator of Bit1 apoptotic function. (2011) (0)
- New Anti-Metastatic and Anti-Angiogenic Compound for Ovarian Cancer (2001) (0)
- The Cell-Penetrating Homing Peptide CAR Selectively Enhances Pulmonary Effects Of Systemically Co-Administered Vasodilators In A Preclinical Model Of Severe Pulmonary Arterial Hypertension (2012) (0)
- Abstract 13022: The Homing Peptide CAR Markedly Enhances the Pulmonary Vasodilator Efficacy and Selectivity of the Rho Kinase Inhibitor Fasudil (2010) (0)
- Targeting Therapy Resistant Tumor Vessels (2007) (0)
- Molecular specialization of b breast-homing phage-display (2016) (0)
- Effect of cyclophosphamide on serum immunoglobulin level in patients with tumours of the genital tract. (1970) (0)
- Distribution andisolation offourlaminin variants; tissue restricted distribution ofheterotrimers assembled fromfive different subunits (1990) (0)
- Paxillin, aTyrosine Phosphorylated Focal Adhesion- associated Protein BindstotheCarboxyl Terminal DomainofFocal Adhesion Kinase (1995) (0)
- Abstract 385: iRGD mediated delivery of neoantigens to enable immunotherapy in integrin b5-rich tumors (2022) (0)
- Early metabolic changes with thiazide therapy for essential hypertension . Results of open label extension study comparison with amiloride (2009) (0)
- Abstract 5415: Targeted nanoparticle based therapy for the treatment of glioblastoma multiforme: Unprecedented anti-cancer activity in highly drug resistant/refractory mouse models of glioblastoma with novel apoptotic nanoparticles which hone to a cell-surface protein f (2014) (0)
- Inhibition of tumor growth by chlorambucil conjugated to a new tumor targeting peptide vector (2008) (0)
- Delivery and Targeting of Therapeutic Cells (2015) (0)
- 100 and 50 years ago (1999) (0)
- Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease (2018) (0)
- Drug delivery: Magnetic Luminescent Porous Silicon Microparticles for Localized Delivery of Molecular Drug Payloads (Small 22/2010) (2010) (0)
- SF-085-5 Tumor penetrating drug delivery for intraperitoneal chemotherapy (2011) (0)
- Targeting Prostate Vasculture (2001) (0)
This paper list is powered by the following services:
Other Resources About Erkki Ruoslahti
What Schools Are Affiliated With Erkki Ruoslahti?
Erkki Ruoslahti is affiliated with the following schools:
